Allylamine antifungal drugs.
Ryder
N S
NS
Mieth
H
H
D000499:Allylamine / Q000031:analogs & derivatives / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D000935:Antifungal Agents / Q000494:pharmacology* / Q000627:therapeutic use; D003881:Dermatomycoses / Q000188:drug therapy*; D004875:Ergosterol / Q000037:antagonists & inhibitors; D056890:Eukaryota / Q000187:drug effects; D005658:Fungi / Q000187:drug effects*; D006801:Humans; D009281:Naphthalenes / Q000494:pharmacology / Q000627:therapeutic use; D010105:Oxygenases / Q000037:antagonists & inhibitors; D050603:Squalene Monooxygenase; D000077291:Terbinafine
D000935:Antifungal Agents; D009281:Naphthalenes; D000499:Allylamine; C029178:naftifine; D010105:Oxygenases; D050603:Squalene Monooxygenase; D000077291:Terbinafine; D004875:Ergosterol